BofA moves to No Rating on Pactiv Evergreen

Novolex to merge with Pactiv Evergreen in $6.7bn deal
Apollo Global Management-owned packaging company Novolex has signed a definitive agreement with Pactiv Evergreen to merge into a combined entity in an all-cash deal valued at $6.7bn.
Apollo-Backed Novolex to Buy Pactiv Evergreen for $3.22 Billion
Novolex, a packaging company backed by Apollo Global Management, struck a deal to buy publicly traded Pactiv Evergreen for around $3.22 billion
BofA moves to No Rating on Pactiv Evergreen after Novolex deal
BofA analyst George Staphos moves to No Rating on Pactiv given the stock is no longer trading on fundamentals following Apollo-owned Novolex
Novolex buying packaging maker Pactiv Evergreen
Packaging maker Novolex Holdings is taking over competitor Pactiv Evergreen Inc., in a deal worth approximately US$6.7 billion. According to a Dec. 9 news release, upon the merger’s completion, Pactiv Evergreen will become a privately held company, and its common stock no longer will be listed on Nasdaq.
Apollo-owned Novolex to take packaging products maker Pactiv private in $6.7 billion deal
(Reuters) -Packaging firm Novolex will buy rival Pactiv Evergreen in a $6.7 billion deal, as the Apollo Global Management-owned firm looks to bolster its business of food and beverage packaging in a cautious economic environment.
Novolex, Pactiv Evergreen to merge in $6.7B deal
The transaction is expected to close in mid-2025, and Novolex CEO Stan Bikulege will lead the combined company.
Novolex buying Pactiv Evergreen in $6.7B deal
The move combines two companies with deep plastics portfolios, including bags, film, thermforms, plastic containers, cutlery, dinnerware and drinkware.
Apollo-backed Novolex and Pactiv Evergreen to merge in $6.7bn deal
The deal is supported by Apollo, the majority shareholder of Novolex since 2022, and Canada Pension Plan Investment Board.
Pactiv Evergreen downgraded to Neutral from Buy at Citi
Citi downgraded Pactiv Evergreen (PTVE) to Neutral from Buy with a price target of $18, up from $13. The firm sees limited upside to the shares
Citigroup Downgrades Pactiv Evergreen (PTVE)
Fintel reports that on December 10, 2024, Citigroup downgraded their outlook for Pactiv Evergreen (NasdaqGS:PTVE) from Buy to Neutral. Analyst Price Forecast Suggests 14.66% Downside As of December 3,
Detroit Free Press1d
Pactiv Evergreen sold for $6.7 billion; Prospective Canton mill buyer 'wants to close'
Pactiv Evergreen will "combine" with Novolex, the Charlotte-based company that bought the company in an all-cash ...
Novolex and Pactiv Evergreen Inc. to Combine, Establishing a Leading Manufacturer in Food and Beverage Packaging
Pactiv Evergreen Shareholders to Receive $18.00 Per Share in Cash Complementary products, focus on innovation and ...
PE Hub15h
Patient Square unveils $4.1bn take-private deal; Bain Capital, Leeds Equity leverage seismic shift in education
Patient Square Capital has agreed to acquire Patterson Companies, a St. Paul, Minnesota-based dental and animal health ...
The Mountaineer2d
Pactiv to sell out; impact on Canton mill is uncertain
Haywood residents who took a chance on investing in Pactiv Evergreen when it went public in 2020 can cash out at a ...